Kura Oncology Inc logo

Kura Oncology Inc

1
NAS:KURA (USA)  
$ 20.95 +0.62 (+3.05%) 11:08 PM EST
At Loss
P/B:
3.16
Volume:
696.16K
Avg Vol (2M):
663.81K
Trade In:
Volume:
696.16K
At Loss
Avg Vol (2M):
663.81K

Business Description

Description
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 31.06
Equity-to-Asset 0.91
Debt-to-Equity 0.03
Debt-to-EBITDA -0.1
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 57.13
9-Day RSI 51.09
14-Day RSI 50.25
6-1 Month Momentum % 75.89
12-1 Month Momentum % 106.25

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 16.67
Quick Ratio 16.67
Cash Ratio 16.34

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.9
Shareholder Yield % -15.4

Financials (Next Earnings Date:2024-08-02 Est.)

KURA's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:KURA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Kura Oncology Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -2.17
Beta 0.26
Volatility % 70.28
14-Day RSI 50.25
14-Day ATR ($) 0.966026
20-Day SMA ($) 20.9985
12-1 Month Momentum % 106.25
52-Week Range ($) 7.41 - 24.17
Shares Outstanding (Mil) 76.18

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Kura Oncology Inc Filings

Filing Date Document Date Form
No Filing Data

Kura Oncology Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Kura Oncology Inc Frequently Asked Questions

What is Kura Oncology Inc(KURA)'s stock price today?
The current price of KURA is $20.95. The 52 week high of KURA is $24.17 and 52 week low is $7.41.
When is next earnings date of Kura Oncology Inc(KURA)?
The next earnings date of Kura Oncology Inc(KURA) is 2024-08-02 Est..
Does Kura Oncology Inc(KURA) pay dividends? If so, how much?
Kura Oncology Inc(KURA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1